title: Topical and intralesional therapies for alopecia areata.
abstract: Alopecia areata is a common form of nonscarring alopecia. It affects males and females equally and has no racial predilection. It usually affects the scalp, but any hair-bearing area can be involved. It presents as patchy hair loss, loss of hair on the entire scalp (alopecia totalis), or the whole body (alopecia universalis). The histopathology varies according to the disease stage, but usually a perifollicular lymphocytic infiltrate is seen. The course of the disease and response to treatment are unpredictable. Various therapeutic modalities are used including topical, intralesional, and systemic agents, although none are curative or preventive. This article will review the available topical and intralesional agents that are used in the treatment of alopecia areata and suggest a management approach based on the age of the patient and extent of the disease.
authors.affiliation: Department of Dermatology, Riyadh Military Hospital, Riyadh, Saudi Arabia. dralkhalifah@hotmail.com
authors.forename: Abdullah
authors.initials: A
authors.lastname: Alkhalifah
mesh_terms: D000287:Administration, Topical; D000367:Age Factors; D000505:Alopecia / Q000188:drug therapy* / Q000473:pathology / Q000628:therapy; D000506:Alopecia Areata / Q000188:drug therapy* / Q000473:pathology / Q000628:therapy; D000818:Animals; D005260:Female; D005938:Glucocorticoids / Q000008:administration & dosage / Q000627:therapeutic use*; D018859:Hair Follicle / Q000473:pathology; D006801:Humans; D015552:Injections, Intralesional; D008214:Lymphocytes / Q000378:metabolism; D008297:Male; D010789:Phototherapy / Q000379:methods; D012720:Severity of Illness Index
chemical_list: D005938:Glucocorticoids